OTC Birth Control

OTC Birth Control

The proverbial ‘pill’ or hormonal contraception may be available over-the-

counter (or at least a progestin-only version) by year’s end. Join guest host, 

Jake Galdo, as he discusses improved access to care with Erin Raney as the 

FDA debates over-the-counter status for hormonal contraceptives.

The GameChanger

Women’s health is a priority area from a public health perspective – the US 

has lots of room for improvement. One initiative is to allow a progestin-only 

hormonal contraceptive have over-the-counter status; in other words, be 

available without prescription. Progestin-only therapy has unique counseling 

considerations, so pharmacy intervention can help to optimize care.

Host

Jake Galdo, PharmD, MBA, BCPS, BCGP

Course Content and Developer, CEimpact

Managing Network Facilitator, CPESN Health Equity

CEO, Seguridad

 
Guest

Erin C. Raney, Pharm.D., BCPS, BC-ADM

Professor of Pharmacy Practice

Midwestern University College of Pharmacy-Glendale

 References and Resources

 Opill Rx-to-OTC Switch Program. www.fda.gov/media/167893/download

 
Redeem your CPE here

CPE (Pharmacist) https://learn.ceimpact.com/library/course/5768

Get a membership & earn CE for GameChangers Podcast episodes (30 

mins/episode)

Pharmacists: Get a membership https://www.ceimpact.com/

 CE Information

 Learning Objectives

 Upon successful completion of this knowledge-based activity, participants 

should be able to:

 1. Discuss the efficacy of OTC hormonal contraceptive

 2. Identify contraindications for OTC hormonal contraceptives

 0.05 CEU/0.5 Hr

 UAN: 0107-0000-23-XXX-H01-P

 Initial release date: XX/XX/2023

 Expiration date: XX/XX/2024

Additional

CPE details can be found here

.Follow CEimpact on Social Media:

LinkedIn

Instagram

Download the CEimpact App for Free Continuing Education + so much more!

Follow CEimpact on Social Media:
LinkedIn
Instagram

Download the CEimpact App for Free Continuing Education + so much more!